Stein, M. N., Vinceneux, A., Robbrecht, D., Doger, B., Autio, K. A., Schweizer, M. T., Calvo, E., Medina, L., Dongen, M. V., Deville, J., Bernard-Tessier, A., Ghosh, D., Shotts, K., Shen, F., Jaiprasart, P., Chaudhary, R., Wu, S., Cartee, L., Schnepp, R., Gaut, D., Lauring, J., Wang, S. C., Villalobos, V. M., Baldini, C. (2025). Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00678